[1]张国栋,潘东明,杨辉,等.平脂颗粒对非酒精性脂肪肝大鼠血脂和肝脂代谢的影响[J].福建医药杂志,2023,45(01):102-106.
　Zhang Guodong,Pan Dongming,Yang Hui,et al.Effect of Pingzhi granule on hepatic lipid metabolism of NAFLD in rats[J].FUJIAN MEDICAL JOURNAL,2023,45(01):102-106.
点击复制

平脂颗粒对非酒精性脂肪肝大鼠血脂和肝脂代谢的影响()
分享到：

《福建医药杂志》[ISSN:1002-2600/CN:35-1071/R]

卷:
45
期数:
2023年01期
页码:
102-106
栏目:
基础研究
出版日期:
2023-02-15

文章信息/Info

Title:
Effect of Pingzhi granule on hepatic lipid metabolism of NAFLD in rats
文章编号:
1002-2600(2023)01-0102-05
作者:
张国栋; 潘东明; 杨辉; 戚欢阳; 杨玲敏; 连周颖; 黄文传1; 黄亦琦1
厦门市医药研究所(厦门 361008)
Author(s):
Zhang Guodong; Pan Dongming; Yang Hui; Qi Huangyang; Yang Lingmin; Lian Zhouyin; Huang Wenchuan; Huang Yiqi
Xiamen Institute of Medicine, Xiamen, Fujian 361008, China
关键词:
非酒精性脂肪肝;  平脂颗粒;  大鼠;  肝脂;  血脂
Keywords:
non-alcoholic fatty liver;  Pingzhi granules;  rats;  liver lipids;  blood lipids
分类号:
R285.5; R575.5
文献标志码:
B
摘要:
目的 探讨平脂颗粒对非酒精性脂肪肝(NAFLD)模型大鼠的治疗作用及机制。方法 将造模成功的60只SD大鼠随机分为空白组、模型组、对照组、平脂颗粒低、中、高剂量治疗组,对照组使用当飞利肝宁胶囊悬浊液灌胃; 待实验结束时检测各组大鼠肝功、血脂和抗氧化应激指标。结果 模型组血液和肝脏中的ALT、AST、TC、TG、LDL-C较空白组均升高,HDL-C明显降低(P<0.01),显示造模成功; 治疗组血清和肝脏中ALT、AST、TC、TG、LDL-C的含量与模型组比较均下降(P<0.01或P<0.05),且平脂颗粒高剂量组HDL-C升高明显(P<0.05); 另外与模型组比较,平脂颗粒中、高剂量治疗组血清MDA下降、SOD升高(P<0.01或P<0.05),病理学观察显示平脂颗粒组能减缓治疗组脂肪肝病变程度,肝细胞脂肪变性及炎性细胞浸润较模型组均有明显改善。结论 平脂颗粒可以通过提高肝脂和血脂代谢水平,减少肝脏过氧化损伤,对NAFDL有良好的治疗作用。
Abstract:
Objective To investigate the effect and the mechanism of Pingzhi granules on prevention and treatment to nonalcoholic fatty liver disease in SD rats with high-fat diet.Methods Healthy SD rats without specific pathogens were fed with high-fat diet for 6 weeks to replicate NAFLD animal model.Pingzhi Granules were used for intervention,and Dangfei Liganning Capsule was used as positive control drug,which was administrated by gavage continuously.At the end of the experiment,liver function,blood lipid and antioxidant stress were detected and pathological examination was conducted.Results Compared with the control group,model group showed raising AST,ALT,TC,TG,and LDL-C both in blood lipid and liver lipid(P<0.01); Compared with the model group,a certain dose of pingzhi granules can not only reduce the body weight,liver wet weight and liver index of NAFLD rats but also regulate blood lipid and liver lipid(reducing TC,TG,LDL-C,ALT,AST(P<0.01 or P<0.05),increasing HDL-C(P<0.05); In the treatment group of medium and high dose group,MDA content decreased and SOD content increased(P<0.01 or P<0.05). Pathological results showed that the hepatocellular steatosis and inflammatory cell infiltration in the treatment group were significantly improved compared with the model group.Conclusion Pingzhi granules have good therapeutic effects on NAFLD not only by promoting lipid metabolism and liver function,but also reducing lipid peroxidation damage.

参考文献/References:

[1] 周涛涛,徐定昌,平菁,等.基于网络药理学研究活血调脂方对糖尿病性脂肪肝糖脂代谢的作用[J].中成药,2022,44(6):1993-1999.
[2] 中华中医药学会脾胃病分会,非酒精性脂肪性肝病中医诊疗专家共识意见(2017)[J].临床肝胆病杂志,2017,33(12):2270-2274.
[3] 黄亦琦,吴秀治,罗友华,等.平脂冲剂治疗脂肪肝临床研究[J].福建中医药,2000,(4):3-5.
[4] 黄亦琦,赵鹏,杨辉,等.葛明胶囊调节血脂作用临床试验[J].辽宁中医药大学学报,2011,8(13):41-43.
[5] 罗友华,杨辉,黄亦琦.平脂颗粒的成型处方优选.中成药,2004,26(9):附5-6.
[6] 孙健,张建龙,褚忠华,等.不同食物诱导的大鼠脂肪肝模型的比较[J].中华实验外科杂志,2013,30(9):1988-1990,4.
[7] 张青峰,刘咏煌.大鼠非酒精性脂肪肝模型的建立[J].四川畜牧兽医,2012,39(12):21-23.
[8] 冯丽辉,万雪峰,郑忠蕊,等.柴苓术芍饮对肝郁脾虚型非酒精性脂肪性肝病大鼠肝组织氧化应激及炎症因子的影响[J].中国中医药科技,2022,29(3):360-363.
[9] 李学军,杨叔禹,聂明,等.二陈汤方加减对2型糖尿病并发脂肪肝模型大鼠血糖、血脂、胰岛素抵抗以及肝功能和肝脏脂肪变的影响[J].中国临床康复,2006,10(11):77-80.
[10] 华爽,吕明慧,刘倩颖,等.糖脂代谢病的发病机制:多重打击学说[J].世界中医药,2019,14(3):638-644.
[11] 潘炟,穆标.中药治疗非酒精性脂肪性肝病研究进展[J].中国处方药,2020,18(12):18-20.
[12] 黄亦琦,杨辉,聂明等.平脂冲剂对实验性脂肪肝的防治作用及病理图像分析[J].中西医结合肝病杂志,2002,(5):279-281.
[13] 黄亦琦,林蔚,杨辉,等.葛明胶囊的毒理学安全性评价[J].福建医药杂志,2012,34(1):6-9.

备注/Memo

备注/Memo:
基金项目:厦门市科技局科技计划项目(3502Z20184055); 福建省卫生计生委中青年骨干人才培养项目(2018ZQN95)
1 厦门市中医院(厦门 361009)
作者简介:张国栋,男(1986～),博士,讲师,主要从事天然药物开发和生理学研究,Email:446471878@qq.com;
黄亦琦(1963～),通信作者,主任医师,主要从事脂代谢病临床基础研究,Email:huangyq502@sina.com
更新日期/Last Update: 2023-02-15